Antiangiogenesis strategies proving valuable against breast and prostate cancer.
D000818:Animals; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D001943:Breast Neoplasms / Q000098:blood supply / Q000188:drug therapy*; D005260:Female; D006801:Humans; D006912:Hydroxyquinolines / Q000627:therapeutic use; D008297:Male; D009389:Neovascularization, Pathologic / Q000188:drug therapy*; D011471:Prostatic Neoplasms / Q000098:blood supply / Q000188:drug therapy*; D051381:Rats; D013629:Tamoxifen / Q000627:therapeutic use
D000970:Antineoplastic Agents; D006912:Hydroxyquinolines; D013629:Tamoxifen; C045282:roquinimex